TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999
TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years September 28, 2012